Q4 2024 Holdings
Filed 2025-02-14 | 26 holdings | $212.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $17.7M | 505,007 | 8.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.9M | 360,000 | 8.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $15.1M | 1,787,003 | 7.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $14.4M | 750,000 | 6.8% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $13.9M | 1,055,000 | 6.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $12.1M | 1,648,523 | 5.7% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $11.0M | 860,000 | 5.2% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $10.1M | 442,761 | 4.8% |
| Evolus Inc(EOLS) | COM | 30052C107 | $9.9M | 895,524 | 4.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $9.6M | 245,272 | 4.5% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $8.7M | 10,980,000 | 4.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $7.9M | 3,170,194 | 3.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $7.1M | 3,009,392 | 3.3% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.9M | 322,380 | 3.2% |
| Merus N V | COM | N5749R100 | $6.6M | 158,092 | 3.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $6.0M | 275,000 | 2.8% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.3M | 500,000 | 2.5% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $4.9M | 300,000 | 2.3% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $4.9M | 4,683,711 | 2.3% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $4.7M | 826,751 | 2.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $4.4M | 228,803 | 2.1% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $4.0M | 1,150,000 | 1.9% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.0M | 621,894 | 1.4% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $2.5M | 2,645,128 | 1.2% |
| Optinose Inc(0OP) | COM NEW | 68404V209 | $2.5M | 370,269 | 1.2% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.0M | 187,843 | 0.9% |